Abstract
We report the case of a 59-year-old woman with stage IV erythrodermic mycosis fungoides (MF) and large cell transformation who, despite failing multiple previous treatments, achieved complete remission through a combination of pralatrexate and romidepsin followed by allogeneic hematopoietic stem cell transplantation (alloSCT). Further studies are needed in focussing on this combined regimen in treating cutaneous T-cell lymphoma (CTCL) and its efficacy as a bridging regimen in facilitating successful alloSCT.
Original language | English |
---|---|
Pages (from-to) | e400-e403 |
Journal | Australasian Journal of Dermatology |
Volume | 62 |
Issue number | 3 |
Early online date | 2021 |
DOIs | |
Publication status | Published - Aug 2021 |